Kitazato Corporation (Ticker: 368A JP) is a Japanese company specializing in the research, development, and manufacturing of medical devices for fertility treatment and assisted reproduction. Kitazato plans to list on the Tokyo Stock Exchange Prime Market on June 25, 2025.

The offering consists of 14 million existing shares with a 2.1 million share over-allotment option, priced in a provisional range of JPY 1,300 to JPY 1,340. The total offer size is up to approximately JPY 21.6 billion (USD 127.85 million), valuing the company at around USD 365.30 million. Nomura Securities and SMBC Nikko Securities are the lead underwriters for the deal.